Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003 FY2002
Operating Activities
Net Income $-2.9M $-3.7M $-4.4M $-6.5M $-6.3M $-3.3M $-2.8M $-1.2M
Depreciation & Amortization $41.6K
Depreciation
Amortization
Stock-Based Compensation $497.5K
Net Cash from Operating Activities $-5.1M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $1.3M
Financing Activities
Dividends Paid
Stock Repurchases $0
Net Cash from Financing Activities $10.7M
Net Change in Cash $6.9M
Free Cash Flow
← Newer Page 3 of 3 Older →